SLC6A3 and dementia: There were 5 patients heterozygous for E326K and 4 patients with compound heterozygosis with other deleterious variants, and none of them had reduced DAT binding in comparison with analogous non-carriers nor displayed signs of dementia after a mean follow-up of 14 years.